Jubilant Pharmova Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jubilant Pharmova has informed the exchanges that its trading window for dealing in company securities will be closed starting April 1, 2026. The window will reopen 48 hours after the company announces its audited standalone and consolidated financial results for the quarter and full year ending March 31, 2026. This is a routine compliance measure under SEBI's Insider Trading Regulations to prevent insiders from trading while in possession of unpublished price-sensitive information. The board meeting date to declare the audited results has not yet been announced and will be communicated separately. Designated persons of the company have been notified not to trade during this closed period.
This is a standard regulatory filing and does not have a direct impact on the stock price. Investors should note that audited FY26 results are expected in the coming weeks, which could be a key catalyst for the stock.